Search results for "Lung cancer"
Study identifies factors behind guideline-discordant use of lung cancer screening
Interviews with 31 primary care physicians suggested that knowledge gaps about the life expectancy threshold at which lung cancer screening's value becomes limited may contribute to their decisions to recommend screening to patients who may not benefit.
https://immattersacp.org/weekly/archives/2024/03/19/2.htm
19 Mar 2024
Treat COPD symptoms, solve problems
Effectively managing chronic obstructive pulmonary disease means staying up to date on medications, devices, and delivery techniques.
https://immattersacp.org/archives/2024/04/treat-copd-symptoms-solve-problems.htm
1 Apr 2024
Lung cancer screening led to more downstream procedures, complications in practice than in research
In clinical practice, 31.9% of patients screened for lung cancer underwent downstream imaging and 2.8% had downstream procedures. Those undergoing invasive procedures after abnormal findings had a 30.6% complication rate, compared to 17.7% in the National Lung Screening Trial.
https://immattersacp.org/weekly/archives/2024/01/09/1.htm
9 Jan 2024
First medication for severe frostbite approved
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2024/04/first-medication-for-severe-frostbite-approved.htm
1 Apr 2024
MKSAP Quiz: Evaluation of lung cancer risk during a routine visit
This week's quiz asks readers to determine the most appropriate lung cancer screening test for a 63-year-old woman with a 37-pack-year history of cigarette smoking who quit smoking at age 55 years and has COPD but reports no symptoms concerning for lung cancer.
https://immattersacp.org/weekly/archives/2023/05/16/3.htm
16 May 2023
Screening for lung cancer a struggle
Lung cancer has an alarmingly low five-year survival rate, but screening, if implemented well, can improve it.
https://immattersacp.org/archives/2018/05/screening-for-lung-cancer-a-struggle.htm
1 May 2018
Personal risk-based screening for lung cancer may be more cost-effective than recommended cutoffs
While risk-based screening strategies were robustly more cost-effective than the 2021 U.S. Preventive Services Task Force recommendation in a modeling study, whether the results will be replicable in complex real-world clinical practice remains uncertain, an editorial noted.
https://immattersacp.org/weekly/archives/2023/02/07/5.htm
7 Feb 2023
USPSTF recommends lung cancer screening for broader patient population
The updated recommendation from the U.S. Preventive Services Task Force (USPSTF) adds 50- to 55-year-olds to the population that should get annual low-dose computed tomography, as well as lowering the pack-year cutoff.
https://immattersacp.org/weekly/archives/2021/03/16/2.htm
16 Mar 2021
Salt tablets no salve for hyponatremia
At Kidney Week in fall 2023, an endocrinologist covered the latest in outpatient diagnosis and treatment of syndrome of inappropriate antidiuresis (SIAD).
https://immattersacp.org/archives/2024/02/salt-tablets-no-salve-for-hyponatremia.htm
1 Feb 2024
Disparities exist in adherence to lung cancer screening follow-up, study finds
Campaigns for improvement should target primary care clinicians to increase awareness of the benefits of lung cancer screening, the authors noted.
https://immattersacp.org/weekly/archives/2021/08/17/5.htm
17 Aug 2021